Terapia genética com betibeglogene autotemcel para betatalassemia não-beta-0/beta-0.
14 Fev, 2022 | 15:39hBetibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
Visual Abstract: Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia. https://t.co/2GOCGxrruv pic.twitter.com/zLvuuuByXN
— NEJM (@NEJM) February 8, 2022